Description:

ODM derived from http://clinicaltrials.gov/show/NCT00717457

Link:

http://clinicaltrials.gov/show/NCT00717457

Keywords:
Versions (2) ▾
  1. 12/9/13
  2. 4/16/14
Uploaded on:

April 16, 2014

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00717457 Diabetes Mellitus, Type 2

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age 18 Years to 75 Years
Adult (person)
type 2 diabetes receiving metformin and/or pioglitazone or rosiglitazone for at least 12 weeks
HbA1c >=7.0% and <=10% at screening
BMI >=25kg/m2 (>23kg/m2 for Asians) and <=45kg/m2 at screening
stable weight +/- 5% for at least 12 weeks prior to screening.
Exclusion Criteria
history of type 1 diabetes, diabetes resulting from pancreatic injury or secondary forms of diabetes
history of acute metabolic diabetic complications within the previous 6 months
evidence of clinically significant diabetic complications
Proliferative diabetic retinopathy
myocardial infarction (MI), coronary artery bypass surgery, post-transplantation cardiomyopathy (PTCM) or stroke within the past 6 months
any abnormality in clinical laboratory test or ECG, which precludes safe involvement in the study as judged by the investigator
known hemoglobinopathy or chronic anemia
clinically significant gastrointestinal disease.